AYM
0.002
100%
CYP
0.018
-93.1%
CLU
0.009
50%
MMR
0.002
-60%
CT1
0.003
50%
BPH
0.004
-50%
VEN
0.003
50%
FBR
0.002
-33.3%
A8G
0.13
44.4%
AGE
0.037
-28.8%
OSL
0.795
34.7%
NES
0.003
-25%
AD8
2.23
27.4%
TMX
0.003
-25%
AM3
0.005
25%
ZMM
0.003
-25%
X2M
0.005
25%
NOR
0.013
-23.5%
PCL
0.011
22.2%
FOS
0.11
-21.4%
IMU
0.115
21.1%
BUY
0.02
-20%
MCP
0.145
20.8%
SPQ
0.004
-20%
ABY
0.32
20.8%
UM1
0.075
-18.5%
RFT
0.006
20%
GTI
0.029
-17.1%
TG1
0.031
19.2%
GLL
0.005
-16.7%
MNE
0.16
18.5%
RMY
0.025
-16.7%
BKT
0.013
18.2%
VHL
0.015
-16.7%
4DX
4.54
17.6%
WAK
0.005
-16.7%
EXL
0.007
16.7%
NVA
0.61
-15.3%
PL9
0.007
16.7%
WCN
0.017
-15%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Arovella Therapeutics (ASX:ALA): TSN -The Stock Network

November 2023: Arovella Therapeutics (ASX:ALA) CEO & Managing Director Michael Baker presents for The Stock Network
.
Learn more about Arovella Therapeutics: https://www.arovella.com/